Back to User profile » Dr Hung-Jen Tang
Papers published by Dr Hung-Jen Tang:
Antimicrobial Susceptibility of E. coli Isolates from Intra-Abdominal Infections in the Asia-Pacific Region: Trends in Ciprofloxacin, Ceftriaxone, Cefepime, and Piperacillin/Tazobactam Susceptibility
Tsai CH, Chen YC, Chen PY, Lai CC, Tang HJ, Chuang YC, Chen CC, Ho CH, Hsu WY, Chang TH
Infection and Drug Resistance 2023, 16:5599-5611
Published Date: 25 August 2023
The Impact of Monthly Prophylactic Antibiotics Use in Patients with Recurrent Cellulitis: A 20-Year Population-Based Cohort Study in a Medical Center
Huang YF, Tang HJ, Hsu HL
Infection and Drug Resistance 2023, 16:3819-3827
Published Date: 15 June 2023
The efficacy and safety of ceftaroline in the treatment of acute bacterial infection in pediatric patients – a systemic review and meta-analysis of randomized controlled trials
Chen CW, Chang SP, Huang HT, Tang HJ, Lai CC
Infection and Drug Resistance 2019, 12:1303-1310
Published Date: 15 May 2019
Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)
Lai CC, Chen YS, Lee NY, Tang HJ, Lee SSJ, Lin CF, Lu PL, Wu JJ, Ko WC, Lee WS, Hsueh PR
Infection and Drug Resistance 2019, 12:627-640
Published Date: 14 March 2019
Antimicrobial activities of ceftazidime–avibactam, ceftolozane–tazobactam, and other agents against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolated from intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan in 2016
Liao CH, Lee NY, Tang HJ, Lee SSJ, Lin CF, Lu PL, Wu JJ, Ko WC, Lee WS, Hsueh PR
Infection and Drug Resistance 2019, 12:545-552
Published Date: 4 March 2019
The efficacy and safety of nemonoxacin compared with levofloxacin in the treatment of community-acquired pneumonia: a systemic review and meta-analysis of randomized controlled trials
Chang SP, Lee HZ, Lai CC, Tang HJ
Infection and Drug Resistance 2019, 12:433-438
Published Date: 14 February 2019
In vitro activity of cefoperazone and cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa
Lai CC, Chen CC, Lu YC, Chuang YC, Tang HJ
Infection and Drug Resistance 2019, 12:25-29
Published Date: 20 December 2018
Simultaneous three Enterobacteriaceae with different bla NDM-1-encoding plasmids in a patient transferred from mainland China to Taiwan
Lai CC, Chen CC, Lu YC, Chen HJ, Su BA, Weng TC, Chiu YH, Toh HS, Zhang CC, Chiang SR, Chuang YC, Tang HJ
Infection and Drug Resistance 2018, 11:2555-2560
Published Date: 7 December 2018
Appropriate composites of cefoperazone–sulbactam against multidrug-resistant organisms
Lai CC, Chen CC, Lu YC, Lin TP, Chuang YC, Tang HJ
Infection and Drug Resistance 2018, 11:1441-1445
Published Date: 11 September 2018
Nationwide surveillance of ribotypes and antimicrobial susceptibilities of toxigenic Clostridium difficile isolates with an emphasis on reduced doxycycline and tigecycline susceptibilities among ribotype 078 lineage isolates in Taiwan
Hung YP, Tsai PJ, Lee YT, Tang HJ, Lin HJ, Liu HC, Lee JC, Tsai BY, Hsueh PR, Ko WC
Infection and Drug Resistance 2018, 11:1197-1203
Published Date: 15 August 2018
The clinical significance of silent mutations with respect to ciprofloxacin resistance in MRSA
Lai CC, Chen CC, Lu YC, Chuang YC, Tang HJ
Infection and Drug Resistance 2018, 11:681-687
Published Date: 3 May 2018